Orshe

One new study estimates the percentage of workers at firms with 50 or fewer employees offered health insurance will rise to 86% from 60% after health-care overhaul is implemented.

Read the original post:  A Whole Lotta Studies on Small Business and Health Insurance

Also: experimental melanoma drug results; California insurance news; radiation at Walter Reed.

Here is the original post:  A.M. Vitals: Judge Won’t Nix Generic Version of Sanofi’s Lovenox

Also: study quantifies radiation from nuclear imaging tests; Genzyme and Sanofi talk price; routine care coverage for clinical trial participants.

View original post here:  A.M. Vitals: Judge Blocks Federal Funding of Embryonic Stem Cell Research

Also: Hepatitis E vaccine study; new self-referral rule for medical imaging; NAIC and HHS on medical-loss ratio.

Original post:  A.M. Vitals: Federal Medical Privacy Rules Go Back for Do-Over

Strategies employers use to keep a lid on costs include cost-sharing, consumer-directed health plans and wellness programs.

Read the original post: Big Employers Estimate Health-Care Costs Will Rise 8.9% in 2011

Researchers say only 4.1% of Mass. residents were uninsured in 2008, the lowest of all states. But who’s included in that 4.1%?

The rest is here:  Who in Massachusetts Doesn’t Have Health Insurance?

In addition to J&J’s bonds: regulators struggle with limited-benefit plans; FDA warns on GSK drug; a weight-loss drug trial.

Continued here: A.M. Vitals: J&J Sets Record With Corporate Bond Rates

Also: Insurance execs got raises last year; are bioweapons getting easier to produce?

Read more: A.M. Vitals: Medicaid Funding For States Clears the House

Also: Perils of Facebook for hospital workers; early puberty in girls; salmonella and pet food.

Read the original post: A.M. Vitals: Insurers Join the Electronic Medical Records Party

Also: state regulators look like David to the health insurance industry’s Goliath; two steps forward in regenerative medicine; how Medicare Advantage cuts may play out.

Original post: A.M. Vitals: Omnicare’s Candid Earnings Call